We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCombined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.AuthorsJaiswal BS; Janakiraman V; Kljavin NM; Eastham-Anderson J; Cupp JE; Liang Y; Davis DP; Hoeflich KP; Seshagiri SPublicationPloS one, 2009, Vol 4, Issue 5, pe5717ISSN1932-6203Publication typearticleDOI10.1371/journal.pone.0005717